|
|
|
|
|
|
|
|
|
|
Course Criteria
Add courses to your favorites to save, share, and find your best transfer school.
-
3.00 Credits
Pr., program approval. Introduces the profession of cytology, including basic cell biology, cell morphology, general criteria of malignancy, purpose, history of the profession, cytogenetics and proper use of the microscope.
-
3.00 Credits
Pr., program approval. Study of the anatomy, histology and normal gynecological cytology, including benign processes associated with infectious organisms, inflammation, degenera- tion, artifacts, vitamin deficiencies and cytohormonal patterns.
-
3.00 Credits
Pr., program approval. Detailed studies in the cytologic diagnosis of pre-malignant and malignant lesions of the female genital tract, including the effects of chemotherapy and radiation. Differential diagnosis of these lesions includes the severity, site of origin and grade where appropriate.
-
2.00 Credits
Pr., program approval. Basic techniques, including specimen receipt, processing, Papnicolaou staining and methodol- ogy, coverslipping, special preparatory techniques of gynecological and non- gynecological specimen, record keeping and filing of slides.
-
1.00 Credits
Pr., program approval. Principles of management, supervision and laboratory safety taught, with emphasis on problem solving and ethical practices as related to cytopathology.
-
3.00 Credits
Pr., program approval. Systematic study of the anatomy, histology, normal and abnormal cytology of malignant and non-malignant lesions of the respiratory tract. Emphasis on cellular changes associated with normal and malignant disease processes and dif- ferential diagnostic considerations.
-
2.00 Credits
Pr., program approval. Study of the anatomy, histology, normal and abnormal cytology of the urinary tract and gastrointestinal tract. Emphasis on interpretation of non- malignant and malignant disease processes at these sites.
-
2.00 Credits
Pr., program approval. Study of the anatomy, histology, normal and abnormal cytology of the CNS, the eye, diseases of serosal cavities in fluids, synovial membranes, and miscellaneous fluids with non-malignant and malignant processes.
-
4.00 Credits
Pr., program approval. Study of the anatomy, histology, normal and abnormal cytology of the breast, thyroid, lymph nodes, soft tissue masses and salivary glands. Emphasis on the problem of differentiating malignant processes and reactive changes.
-
3.00 Credits
Pr., program approval. Students integrate didactic knowledge into the clinical laboratory setting. Practical experi- ence gained by working with routine cytology material from all body sites under close supervision. Includes specimen preparation and obser- vation of fine needle biopsy technique. 4680. Journal Club in Cytopathology (1) Pr., program approval. Evaluation of current professional literature pertaining to diagnostic cytology. Reports, critiques and discussions by students and faculty. 4684. Clinical Internship II (8) Pr., program approval. Students integrate didactic knowledge into the clinical laboratory setting. Further practical experience gained by working with routine cytology material from all body sites under close supervision. Includes specimen preparation and observation of fine needle biopsy technique. 4690. Research Project in Cytopathology (2) Pr., program approval. Students investigate topic of interest in cytopathology. Analyzing data, writing a paper and presenting to fellow students and faculty. 4700. Senior Seminar in Cytopathology (3) Pr., program approval. Unusual and interesting cases studied and discussed. Review for preparation of comprehensive examination in cytotechnology, including computer image reviews. 4710. Advances in Diagnostic GYN/NGYN Cytology (1-8) Pr., program approval. Students present papers on new advances in the field of cytol ogy. Presentations emphasize new advances in cytology automation.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Privacy Statement
|
Terms of Use
|
Institutional Membership Information
|
About AcademyOne
Copyright 2006 - 2025 AcademyOne, Inc.
|
|
|